stars 1 stars 2 stars 3

ANS Biotech is a preclinical CRO fully dedicated to the in vivo pharmacology of pain. Since 2006 we have serviced more than 160 worldwide clients from Pharma and Biotech to build their preclinical portfolio, assisting in the positioning / repositioning of their analgesic products within precise product profiles. As your partner we work as an extension of your scientific team. We support your drug discovery and development efforts by offering: - SCREENING IN PAIN to profile your drug candidates - MODELS & TESTS IN PAIN: tailored solutions for the management of your research projects based on clinically relevant and predictive in vivo models of pain. ANS Biotech commits itself to providing preclinical pharmacology services performed to the highest ethical and quality standards. ANS Biotech optimizes and accelerates the development of your analgesic candidates.

ANS Biotech Questions

The ANS Biotech annual revenue was $1 million in 2026.

Francois Caussade is the President and Chief Executive Officer of ANS Biotech.

10 people are employed at ANS Biotech.

ANS Biotech is based in Riom, Auvergne-Rhone-Alpes.

The NAICS codes for ANS Biotech are [541, 5417, 541713, 54171, 54].

The SIC codes for ANS Biotech are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users